Literature DB >> 25511809

Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.

Farouk Semcheddine1, Nida El Islem Guissi, XueYin Liu, ZuoMin Wu, Bo Wang.   

Abstract

The aims of this study were to enhance the solubility and dissolution rate of nimodipine (ND) by preparing the inclusion complexes of ND with sulfobutylether-b-cyclodextrin (SBE-β-CD) and 2-hydroxypropyl-b-cyclodextrin (HP-β-CD) and to study the effect of the preparation method on the in vitro dissolution profile in different media (0.1 N HCl pH 1.2, phosphate buffer pH 7.4, and distilled water). Thus, the inclusion complexes were prepared by kneading, coprecipitation, and freeze-drying methods. Phase solubility studies were conducted to characterize the complexes in the liquid state. The inclusion complexes in the solid state were investigated with differential scanning calorimetry (DSC), X-ray diffractometry (X-RD), and Fourier transform infrared spectroscopy (FT-IR). Stable complexes of ND/SBE-β-CD and ND/HP-β-CD were formed in distilled water in a 1:1 stoichiometric inclusion complex as indicated by an AL-type diagram. The apparent stability constants (Ks) were 1334.4 and 464.1 M(-1) for ND/SBE-β-CD and ND/HP-β-CD, respectively. The water-solubility of ND was significantly increased in an average of 22- and 8-fold for SBE-β-CD and HP-β-CD, respectively. DSC results showed the formation of true inclusion complexes between the drug and both SBE-β-CD and HP-β-CD prepared by the kneading method. In contrast, crystalline drug was detectable in all other products. The dissolution studies showed that all the products exhibited higher dissolution rate than those of the physical mixtures and ND alone, in all mediums. However, the kneading complexes displayed the maximum dissolution rate in comparison with drug and other complexes, confirming the influence of the preparation method on the physicochemical properties of the products.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25511809      PMCID: PMC4444620          DOI: 10.1208/s12249-014-0257-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  31 in total

1.  Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems.

Authors:  P Mura; M T Faucci; P L Parrini; S Furlanetto; S Pinzauti
Journal:  Int J Pharm       Date:  1999-03-01       Impact factor: 5.875

2.  Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.

Authors:  Ankitkumar S Jain; Abhijit A Date; Raghuvir R S Pissurlenkar; Evans C Coutinho; Mangal S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2011-09-15       Impact factor: 3.246

3.  Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.

Authors:  Haohao Zhang; Meiwan Chen; Zixin He; Zhouhua Wang; Meimei Zhang; Zhouyang He; Qian Wan; Dan Liang; Michael A Repka; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-11-17       Impact factor: 3.246

4.  Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.

Authors:  G Dollo; P Le Corre; M Chollet; F Chevanne; M Bertault; J L Burgot; R Le Verge
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

5.  Analytical study of photodegradation of inclusion complexes of nimodipine with alpha-, gamma-cyclodextrin, methyl-beta-cyclodextrin, and hydroxypropyl-beta-Cyclodextrin.

Authors:  J Mielcarek
Journal:  Drug Dev Ind Pharm       Date:  1998-02       Impact factor: 3.225

6.  Separation of neutral dihydropyridines and their enantiomers using electrokinetic chromatography.

Authors:  Ann Van Eeckhaut; Marc Robert Detaevernier; Yvette Michotte
Journal:  J Pharm Biomed Anal       Date:  2004-11-19       Impact factor: 3.935

7.  Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.

Authors:  Sateeshkumar Sathigari; Gurkishan Chadha; Y-H Phillip Lee; Nydeia Wright; Daniel L Parsons; Vijay K Rangari; Oladiran Fasina; R Jayachandra Babu
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

Review 8.  The utility of cyclodextrins for enhancing oral bioavailability.

Authors:  Rebecca L Carrier; Lee A Miller; Imran Ahmed
Journal:  J Control Release       Date:  2007-08-16       Impact factor: 9.776

9.  Synthesis and characterization of beta-cyclodextrin inclusion complex containing di(8-hydroxyquinoline) magnesium.

Authors:  Jiang He; Li Deng; Shanshan Yang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2008-09       Impact factor: 4.098

10.  Cyclodextrin inclusion complex to improve physicochemical properties of herbicide bentazon: exploring better formulations.

Authors:  Claudia Yáñez; Paulina Cañete-Rosales; Juan Pablo Castillo; Nicole Catalán; Tomás Undabeytia; Esmeralda Morillo
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more
  5 in total

1.  Nimodipine Ophthalmic Formulations for Management of Glaucoma.

Authors:  Doaa Nabih Maria; Abd-Elgawad Helmy Abd-Elgawad; Osama Abd-Elazeem Soliman; Marwa Salah El-Dahan; Monica M Jablonski
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

2.  Cyclodextrin Derivative Enhances the Ophthalmic Delivery of Poorly Soluble Azithromycin.

Authors:  Anil Thakur; Sourabh Jain; Anjali Pant; Akanksha Sharma; Rajiv Kumar; Neha Singla; Ashish Suttee; Santosh Kumar; Ravi P Barnwal; Om Prakash Katare; Gurpal Singh
Journal:  ACS Omega       Date:  2022-06-24

3.  Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.

Authors:  Suzan M Mansour; Rehab N Shamma; Kawkab A Ahmed; Nirmeen A Sabry; Gamal Esmat; Azza A Mahmoud; Amr Maged
Journal:  Int Immunopharmacol       Date:  2021-07-23       Impact factor: 4.932

4.  Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation.

Authors:  Dinesh M Bramhane; Preethi A Kulkarni; Elvis A F Martis; Raghuvir R S Pissurlenkar; Evans C Coutinho; Mangal S Nagarsenker
Journal:  J Pharm Bioallied Sci       Date:  2016 Apr-Jun

5.  Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.

Authors:  Marian Novac; Adina Magdalena Musuc; Emma Adriana Ozon; Iulian Sarbu; Mirela Adriana Mitu; Adriana Rusu; Daniela Gheorghe; Simona Petrescu; Irina Atkinson; Dumitru Lupuliasa
Journal:  Molecules       Date:  2022-03-21       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.